Does Medicare Part D Cover Mounjaro for Weight Loss? 2026 Criteria
If you’re on Medicare and wondering about Mounjaro coverage for weight management. Here’s the definitive 2026 breakdown of coverage criteria, costs, and alternatives.
Does Medicare Cover Mounjaro?
Mounjaro (tirzepatide) is FDA-approved for type 2 diabetes only. The obesity version, Zepbound, is the same drug but carries the FDA obesity indication.
For type 2 diabetes: Medicare Part D plans do cover Mounjaro for glycemic control. Most plans list it at Tier 4 or Tier 5 (non-preferred or specialty). PA is mandatory on virtually all Part D formulary.
For weight loss: Medicare Part D does not cover Mounjaro for weight management. Federal law prevents coverage of drugs prescribed solely for obesity. Unlike Wegovy Wegovy, Mounjaro does not have a cardiovascular risk reduction indication, so the cardiovascular coverage door remains closed for tirzepatide on Medicare.
What You’ll Pay
For the glycemic control indication:
| Coverage Phase | Monthly Cost Estimate |
|---|---|
| Deductible phase | Full cost (~$1,100/month) |
| Initial coverage | $150-$400/month (25-33% coinsurance) |
| Coverage gap | $300-$500/month |
| Catastrophic coverage | $0-$55/month (5%) |
The Inflation Reduction Act maximum limits total yearly drug costs. Manufacturer copay assistance cannot be used with Medicare — federal law prohibits it.
Approval Process
Medicare Part D PA for Mounjaro demands:
- Type 2 diabetes diagnosis: HbA1c ≥ 7% from the past 6 months
- First-line evidence: Records showing cheaper drugs were tried. Most Part D formularies also require a additional oral medication trial
- Risk assessment: Cleared for tirzepatide
- Provider rationale: Justification for the dual GIP/GLP-1
Processing: 24-72 hours standard; same-day expedited. Part D regulations demand faster PA processing than commercial insurers.
Appeal Process
The structured appeal ladder:
- Redetermination: Submit additional clinical documentation
- Level 2: Independent review
- ALJ hearing: Judicial review
- Levels 4-5: Final review options
Missing deadlines forfeits your rights. Engage a Medicare counselor to strengthen your case.
Medicare won’t cover Mounjaro for weight loss? Compounded semaglutide is available from licensed US telehealth providers for $199/month without insurance.
See Also
- Medicare Ozempic — semaglutide for diabetes on Part D
- Medicare Wegovy — the only semaglutide with CVD coverage on Medicare
- Medicare Zepbound — tirzepatide for obesity (very limited coverage)
- Medicare Rybelsus — the pill-form option
- Kaiser Mounjaro — Kaiser Permanente’s specific policies
Frequently Asked Questions
Does Medicare Part D cover Mounjaro for weight loss?
No. Federal rules prohibit coverage of Mounjaro for weight loss. It’s covered only for type 2 diabetes. The cardiovascular workaround doesn’t apply to tirzepatide.
How much does Mounjaro cost on Medicare?
When covered, costs fall between $150-$500/month depending on benefit period. IRA protections limit your exposure.
Can I get Mounjaro for weight loss through Medicare Advantage?
No. Medicare Advantage follows the same formulary restrictions. Weight-loss medications are not covered.
Disclaimer: This article is for informational purposes only and does not constitute medical or insurance advice. Medicare coverage policies are complex and change annually. Consult your healthcare provider and your Medicare Part D plan for personalized guidance.